Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,40117,420 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Integration of stromal targeting agents with immune checkpoint therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDA) is enriched with activated stellate cells and hyaluronic acids (HA) that contribute to the cancer’s poor prognosis. Our recent publication ha...

Completed NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Administrative Core Summary/Abstract The overall goal of the Administrative Core is to maximize integration of all projects and cores, and collaborations among Program Investigator...

Completed NON-SBIR/STTR RPGS
Core D: Digital Pathology and CyTOF
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY The Digital Pathology and Mass Cytometry Core (Core D) will provide state-of-the-art technologies to enable high-parameter single-cell proteomic profiling for all t...

Completed NON-SBIR/STTR RPGS
Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance
NATIONAL CANCER INSTITUTE Suny Downstate Medical Center United States 2021 – 2026

PROGRAM SUMMARYRadiological imaging is often the first step of the diagnostic pathway for many devastating diseases; thus, an erroneous assessment of “normal” can lead to death. Wh...

$5.28M
USD
Completed NON-SBIR/STTR RPGS
Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2021 – 2026

Cancer is a major cause of morbidity and mortality in the US, with 1.8 million cases and 600 thousand cancer deaths projected for 2020. Substantial progress in cancer treatment has...

$3.43M
USD
Active NON-SBIR/STTR RPGS
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2027

ABSTRACT Immune checkpoint inhibitors (ICIs) are a powerful and innovative mode of cancer therapy, believed to be partially responsible for the largest single-year drop in cancer m...

$22.81M
USD
Completed NON-SBIR/STTR RPGS
Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Summary/Abstract The University of Wisconsin Carbone Cancer Center (UWCCC), Duke University and Memorial Sloan Kettering Cancer Center (MSKCC) seek support for establishing...

$3.19M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood. The consequence of this lack o...

$6.05M
USD
Completed NON-SBIR/STTR RPGS
Mechanistic understanding of the lifecycle of a circulating hybrid cell
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Metastatic disease accounts for >90% of cancer-related deaths worldwide, yet this phase of tumor progression is the least biologically understood. The consequence of this lack o...

$134.8K
USD
Active NON-SBIR/STTR RPGS
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

ABSTRACT While overall colorectal cancer (CRC) incidence and mortality have declined over the last several decades, CRC incidence and mortality rates continue to be higher in Afric...

$1.54M
USD
Completed TRAINING, INDIVIDUAL
Role of IRF2BP2 in Tumor Immune Evasion
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

PROJECT ABSTRACT Understanding the tumor microenvironment (TME) and the prognostic relevance of the cells contributing to it is vital for developing novel treatments for medullobla...

$539.7K
USD
Completed NON-SBIR/STTR RPGS
PAI-1-mediated early-onset endometrial cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

ABSTRACT PAI-1-mediated early-onset endometrial cancer Over the last 15-years, an increase in obesity-associated endometrial cancer has been observed, coinciding with the globesity...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer
NATIONAL CANCER INSTITUTE University of Georgia United States 2021 – 2025

Abstract Bladder cancer is the sixth most prevalent cancer malignancy. More than 80,000 new cases are diagnosed in the USA each year, among which 75% are non-muscle-invasive bladde...

$5.04M
USD
Completed NON-SBIR/STTR RPGS
Sensitizing Ovarian Cancer To PARP inhibitor and platinum treatment
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

Abstract Homologous recombination (HR) is an important DNA repair mechanism for DNA damage caused by PARPi and platinum. The HR pathway is closely associated with ovarian cancer de...

$3.46M
USD
Completed NON-SBIR/STTR RPGS
Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Perinatal smoking negatively affects the baby and mother as well as healthcare costs; yet, up to one third of women who smoke continue to do so during pregnancy. We tested an SMS t...

$5.28M
USD
Completed OTHER RESEARCH-RELATED
Malawi Cancer Outcomes Research Program (M-CORP)
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there were more than 18 million new cancer cases and 9.5 mil...

$2.68M
USD
Completed NON-SBIR/STTR RPGS
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

Abstract Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with high- risk acute myeloid leukemia (AML). However, HSCT is affect...

$3.27M
USD
Completed NON-SBIR/STTR RPGS
B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Title: B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity Non-Hodgkin's lymphomas (NHL) are a...

$3.46M
USD
Completed NON-SBIR/STTR RPGS
Racial and Socioeconomic Disparities in Breast Cancer Diagnostic Work Up and Outcomes
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

Project Summary U.S. women of minority race/ethnicity, lower education, lower income, rural residence, and the underinsured experience higher breast cancer disease burden and lower...

$6.61M
USD
Completed TRAINING, INDIVIDUAL
Investigating the Metabolic Reprogramming of Ovarian Tumors During Omental Metastasis
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2024

ABSTRACT Ovarian cancer (OC) is the most lethal gynecological malignancy, with aggressive metastatic disease responsible for the majority of ovarian cancer related deaths.Despite t...

$510.4K
USD